Evidence map›Paper›PMID 28321079›Full record

ArticleInternal medicine (Tokyo, Japan)2017

Shewanella algae Bacteremia in an End-stage Renal Disease Patient: A Case Report and Review of the Literature.

Tomoaki Takata, Hiroki Chikumi, Shota Morishita, Shintaro Hamada, Shotaro Hoi, Takuji Iyama, Takeaki Fukui, Tomomitsu Matono, Satoko Fukuda, Chishio Munemura and 1 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Prevalence and pathogenic potential ofFrontiers in microbiology · 2025
    Article
  4. Review
  5. Case Report:F1000Research · 2023
    Article
  6. Article
  7. The Fulminating Course of Infection Caused byInfection and drug resistance · 2022
    Article
  8. Emerging Infections Due toFrontiers in medicine · 2022
    Article
  9. Article
  10. A rare case ofBMJ case reports · 2019
    Article
  11. Article
  12. Genome Sequence of Colistin-Resistant BacteremicThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Tomoaki TakataDivision of Medicine and Clinical Science, Tottori University Faculty of Medicine, Japan.
Hiroki Chikumi
Shota Morishita
Shintaro Hamada
Shotaro Hoi
Takuji Iyama
Takeaki Fukui
Tomomitsu Matono
Satoko Fukuda
Chishio Munemura
Hajime Isomoto
Tottori University · JPTottori University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 71-year-old man was admitted because of nausea and abdominal pain. He was receiving an erythropoiesis-stimulating agent for anemia and dysregulated iron metabolism due to stage G5 chronic kidney disease. He had a history of raw fish intake and was diagnosed with infectious enterocolitis, which worsened and led to septic shock. Shewanella putrefaciens grew in the blood culture, but Shewanella algae was identified in a 16S rRNA gene sequence analysis. We herein report a case of S. algae bacteremia believed to have been transmitted orally. We also reviewed previous case reports on Shewanella infection in end-stage renal disease patients.

Indexed as

ShewanellaAgedAnimalsBacteremiaGram-Negative Bacterial InfectionsHumansKidney Failure, ChronicMaleRenal Insufficiency, ChronicRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID28321079
PMCPMC5410489
OpenAlexW2596387741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.